Jørgen Hilden
Associate professor emeritus, Associate Professor emeritus
Section of Biostatistics
Ãster Farimagsgade 5 opg. B, Postboks 2099
1014 København K
Denmark
Member of:
1 - 3 out of 3Page size: 10
- 2004
- Published
Diagnostik: nye metodologiske initiativer
Magid, E., Jørgensen, P. E., Jørgensen, L. G., Madsen, J. S., Larsen, T. B. & Hilden, Jørgen, 2004, In: Ugeskrift for læger. 166, 18, p. 1664-6 2 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Klaringsrapporterne 1996-2001. Lave anførte evidensniveauer for den diagnostiske traefsikkerhed af anbefalede klinisk-biokemiske undersøgelser
Jørgensen, P. E., Madsen, J. S., Jørgensen, L. G., Larsen, T. B., Hilden, Jørgen & Magid, E., 2004, In: Ugeskrift for læger. 166, 18, p. 1667-70 3 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Should CA-125 response criteria be preferred to response evaluation criteria in solid tumors (RECIST) for prognostication during second-line chemotherapy of ovarian carcinoma?
Gronlund, B., Høgdall, Claus Kim, Hilden, Jørgen, Engelholm, S. A., Høgdall, Estrid Vilma Solyom & Hansen, H. H., 2004, In: Journal of Clinical Oncology. 22, 20, p. 4051-8 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 314941
Most downloads
-
165
downloads
Pain relief that matters to patients: systematic review of empirical studies assessing the minimum clinically important difference in acute pain
Research output: Contribution to journal › Review › Research › peer-review
Published -
149
downloads
10-Year Associations Between Tumor Necrosis Factor Receptors 1 and 2 and Cardiovascular Events in Patients With Stable Coronary Heart Disease: A CLARICOR (Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease) Trial Substudy
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
140
downloads
Predictors for major cardiovascular outcomes in stable ischaemic heart disease (PREMAC): statistical analysis plan for data originating from the CLARICOR (clarithromycin for patients with stable coronary heart disease) trial
Research output: Contribution to journal › Journal article › Research › peer-review
Published